Suchergebnisse - "Unizony, Sebastian"

PubPharm (90)

41

Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab

enthalten in: Arthritis & Rheumatology | 2019

von Stone, J. | Tuckwell, K. | Dimonaco, S. | +13

42

Pearls & Oy-sters : Neuro-Sweet disease presenting as ischemic stroke and aseptic meningitis

enthalten in: Neurology | 2018

von Das, A. | Conway, S. | Unizony, S. | +3

43

IL-6 Blockade and its Therapeutic Success in Giant Cell Arteritis

enthalten in: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society | 2018

von Unizony, S. | Kermani, T.

44

Trial of Tocilizumab in Giant-Cell Arteritis

enthalten in: The New England journal of medicine | 2017

von Stone, J. | Tuckwell, K. | Dimonaco, S. | +13

CommentIn: N Engl J Med. 2017 Jul 27;377(4):385-386. - PMID 28745998

45

Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

enthalten in: Arthritis care & research | 2017

von Wallace, Z. | Miloslavsky, E. | Cascino, M. | +14

46

Nationwide Trends in Hospitalizations and In-Hospital Mortality in Granulomatosis With Polyangiitis (Wegener's)

enthalten in: Arthritis care & research | 2017

von Wallace, Z. | Lu, N. | Miloslavsky, E. | +3

47

An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy

enthalten in: Annals of the rheumatic diseases | 2017

von Miyabe, C. | Miyabe, Y. | Strle, K. | +4

48

Newly diagnosed vs. relapsing giant cell arteritis : Baseline data from the GiACTA trial

enthalten in: Seminars in arthritis and rheumatism | 2017

von Tuckwell, K. | Collinson, N. | Dimonaco, S. | +10

49

Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2017

von Unizony, S. | Lu, N. | Tomasson, G. | +5

CommentIn: Arthritis Rheumatol. 2017 Jan;69(1):3-5. - PMID 28029235

50

Serum osteopontin : a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab-treated patients

enthalten in: RMD open | 2017

von Prieto-González, S. | Terrades-García, N. | Corbera-Bellalta, M. | +12